48 related articles for article (PubMed ID: 5284416)
1. HLA alloimmunization and blood requirements in orthotopic liver transplantation.
Marino IR; Weber T; Kang YG; Esquivel CO; Starzl TE; Duquesnoy R
Transplant Proc; 1989 Feb; 21(1 Pt 1):789-91. PubMed ID: 2650271
[No Abstract] [Full Text] [Related]
2. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.
Bekierkunst A; Wang L; Toubiana R; Lederer E
Infect Immun; 1974 Nov; 10(5):1044-50. PubMed ID: 16558087
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans.
Livingston PO; Ragupathi G
Cancer Immunol Immunother; 1997 Oct; 45(1):10-9. PubMed ID: 9353422
[TBL] [Abstract][Full Text] [Related]
4. The role of circulating antibody in the control of metastases.
Lewis MG
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
[No Abstract] [Full Text] [Related]
5. Virulence of six strains of Mycobacterium bovis (BCG) in mice.
Sher NA; Chaparas SD; Pearson J; Chirigos M
Infect Immun; 1973 Nov; 8(5):736-42. PubMed ID: 4584050
[TBL] [Abstract][Full Text] [Related]
6. Immune therapy of malignant melanoma.
Can Med Assoc J; 1972 Sep; 107(5):390-1. PubMed ID: 4561532
[No Abstract] [Full Text] [Related]
7. Progress of immunotherapy in the treatment of malignant melanoma.
Ariyan S
Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459
[No Abstract] [Full Text] [Related]
8. Immunotherapy as an adjunct to surgery in the treatment of cancer.
Eilber FR; Holmes EC; Morton DL
World J Surg; 1977 Sep; 1(5):547-54. PubMed ID: 602232
[No Abstract] [Full Text] [Related]
9. The role of immunotherapy in the management of patients with malignant melanoma.
Goodnight JE; Morton DL
World J Surg; 1979 Jul; 3(3):309-20. PubMed ID: 382645
[No Abstract] [Full Text] [Related]
10. [The immunology of malignant melanoma (author's transl)].
Schieferstein G
Klin Wochenschr; 1978 Mar; 53(16):241-53. PubMed ID: 355711
[No Abstract] [Full Text] [Related]
11. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
12. Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes.
Krementz ET; Mansell PW; Hornung MO; Samuels MS; Sutherland CA; Benes EN
Cancer; 1974 Feb; 33(2):394-401. PubMed ID: 4360056
[No Abstract] [Full Text] [Related]
13. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
14. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
15. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
16. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
Southam CM
J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
